| White matter microstructural alterations across four major psychiatric disorders: mega-analysis study in 2937 individuals D Koshiyama, M Fukunaga, N Okada, K Morita, K Nemoto, K Usui, ... Molecular psychiatry 25 (4), 883-895, 2020 | 202 | 2020 |
| Metabolite changes and gender differences in schizophrenia using 3-Tesla proton magnetic resonance spectroscopy (1H-MRS) SY Tayoshi, S Sumitani, K Taniguchi, S Shibuya-Tayoshi, S Numata, J Iga, ... Schizophrenia research 108 (1-3), 69-77, 2009 | 140 | 2009 |
| Gene expression and association analysis of vascular endothelial growth factor in major depressive disorder J Iga, S Ueno, K Yamauchi, S Numata, S Tayoshi-Shibuya, S Kinouchi, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 31 (3), 658-663, 2007 | 138 | 2007 |
| GABA concentration in schizophrenia patients and the effects of antipsychotic medication: a proton magnetic resonance spectroscopy study SY Tayoshi, M Nakataki, S Sumitani, K Taniguchi, S Shibuya-Tayoshi, ... Schizophrenia research 117 (1), 83-91, 2010 | 131 | 2010 |
| The Val66Met polymorphism of the brain‐derived neurotrophic factor gene is associated with psychotic feature and suicidal behavior in Japanese major depressive patients JI Iga, SI Ueno, K Yamauchi, S Numata, S Tayoshi‐Shibuya, S Kinouchi, ... American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 144 …, 2007 | 114 | 2007 |
| DNA methylation signatures of peripheral leukocytes in schizophrenia M Kinoshita, S Numata, A Tajima, S Shimodera, S Ono, A Imamura, J Iga, ... Neuromolecular medicine 15, 95-101, 2013 | 94 | 2013 |
| Quality of life and cognitive dysfunction in people with schizophrenia Y Ueoka, M Tomotake, T Tanaka, Y Kaneda, K Taniguchi, M Nakataki, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 35 (1), 53-59, 2011 | 94 | 2011 |
| Positive association of the PDE4B (phosphodiesterase 4B) gene with schizophrenia in the Japanese population S Numata, S Ueno, J Iga, H Song, M Nakataki, SY Tayoshi, S Sumitani, ... Journal of psychiatric research 43 (1), 7-12, 2008 | 65 | 2008 |
| A significant causal association between C-reactive protein levels and schizophrenia M Inoshita, S Numata, A Tajima, M Kinoshita, H Umehara, M Nakataki, ... Scientific reports 6 (1), 26105, 2016 | 57 | 2016 |
| Elevated peripheral blood glutamate levels in major depressive disorder M Inoshita, H Umehara, S Watanabe, M Nakataki, M Kinoshita, Y Tomioka, ... Neuropsychiatric Disease and Treatment, 945-953, 2018 | 56 | 2018 |
| Clinical correlates associated with cognitive dysfunction in people with schizophrenia T Tanaka, M Tomotake, Y Ueoka, Y Kaneda, K Taniguchi, M Nakataki, ... Psychiatry and clinical neurosciences 66 (6), 491-498, 2012 | 42 | 2012 |
| Gene expression and association analyses of the phosphodiesterase 4B (PDE4B) gene in major depressive disorder in the Japanese population S Numata, J Iga, M Nakataki, SY Tayoshi, K Taniguchi, S Sumitani, ... American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 150 …, 2009 | 38 | 2009 |
| Glucocorticoid administration improves aberrant fear-processing networks in spider phobia M Nakataki, LM Soravia, S Schwab, H Horn, T Dierks, W Strik, R Wiest, ... Neuropsychopharmacology 42 (2), 485-494, 2017 | 37 | 2017 |
| Positive association of the pericentrin (PCNT) gene with major depressive disorder in the Japanese population S Numata, J Iga, M Nakataki, SY Tayoshi, T Tanahashi, M Itakura, S Ueno, ... Journal of Psychiatry and Neuroscience 34 (3), 195-198, 2009 | 36 | 2009 |
| Decreased serum pyridoxal levels in schizophrenia: meta-analysis and Mendelian randomization analysis Y Tomioka, S Numata, M Kinoshita, H Umehara, S Watanabe, M Nakataki, ... Journal of Psychiatry and Neuroscience 43 (3), 194-200, 2018 | 32 | 2018 |
| 1H-magnetic resonance spectroscopy study of glutamate-related abnormality in bipolar disorder H Kubo, M Nakataki, S Sumitani, J Iga, S Numata, N Kameoka, ... Journal of Affective Disorders 208, 139-144, 2017 | 31 | 2017 |
| Lithium decreases VEGF mRNA expression in leukocytes of healthy subjects and patients with bipolar disorder K Kikuchi, J Iga, S Tayoshi, M Nakataki, S Watanabe, S Numata, T Ohmori Human Psychopharmacology: Clinical and Experimental 26 (4-5), 358-363, 2011 | 31 | 2011 |
| Phase-dependent modulation of signal transmission in cortical networks through tACS-induced neural oscillations KD Fehér, M Nakataki, Y Morishima Frontiers in human neuroscience 11, 471, 2017 | 27 | 2017 |
| Microarray analysis of global gene expression in leukocytes following lithium treatment S Watanabe, J Iga, A Nishi, S Numata, M Kinoshita, K Kikuchi, M Nakataki, ... Human Psychopharmacology: Clinical and Experimental 29 (2), 190-198, 2014 | 26 | 2014 |
| Effect of cognitive function on jumping to conclusion in patients with schizophrenia T Takeda, M Nakataki, M Ohta, S Hamatani, K Matsuura, T Ohmori Schizophrenia research: cognition 12, 50-55, 2018 | 23 | 2018 |
